These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15103197)

  • 1. Pharmacodiagnostic value of the HER family in head and neck squamous cell carcinoma.
    Schartinger VH; Kacani L; Andrle J; Schwentner I; Wurm M; Obrist P; Oberaigner W; Sprinzl GM
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(1):21-6. PubMed ID: 15103197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.
    Xia W; Lau YK; Zhang HZ; Xiao FY; Johnston DA; Liu AR; Li L; Katz RL; Hung MC
    Clin Cancer Res; 1999 Dec; 5(12):4164-74. PubMed ID: 10632356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.
    Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G
    Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin.
    Maubec E; Duvillard P; Velasco V; Crickx B; Avril MF
    Anticancer Res; 2005; 25(2B):1205-10. PubMed ID: 15865067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
    O-Charoenrat P; Rhys-Evans P; Eccles S
    Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma.
    Schlauder SM; Calder KB; Moody P; Morgan MB
    Am J Dermatopathol; 2007 Dec; 29(6):559-63. PubMed ID: 18032952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor biology in head and neck cancer.
    Kalyankrishna S; Grandis JR
    J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
    Do NY; Lim SC; Im TS
    Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
    Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
    Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
    Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
    Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
    Masuda M; Suzui M; Lim JT; Weinstein IB
    Clin Cancer Res; 2003 Aug; 9(9):3486-91. PubMed ID: 12960141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
    Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
    Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
    Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
    Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
    Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
    J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
    Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma.
    López F; Llorente JL; Oviedo CM; Vivanco B; Marcos CÁ; García-Inclán C; Scola B; Hermsen MA
    Cancer; 2012 Apr; 118(7):1818-26. PubMed ID: 22009799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.